672309-93-2 Usage
Uses
Used in Pharmaceutical Synthesis:
N-(4-CARBOXYLIC)BENZOYL-4-PIPERIDONE is utilized as a precursor in the synthesis of various pharmaceuticals and organic compounds. Its unique structure and functional groups make it a valuable building block for developing new drugs with specific therapeutic targets.
Used in Neurological Disorders Treatment:
In the field of medicinal chemistry, N-(4-CARBOXYLIC)BENZOYL-4-PIPERIDONE is used as a potential therapeutic agent for neurological disorders. Its ability to inhibit glutamate release in rat cortical neurons suggests that it may have neuroprotective properties, which could be beneficial in conditions associated with excitotoxicity, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Used in Research and Development:
N-(4-CARBOXYLIC)BENZOYL-4-PIPERIDONE is also used in research and development settings to explore its pharmacological properties further. Ongoing studies aim to understand its mechanism of action, potential side effects, and optimal dosages for therapeutic use. This research is crucial for advancing the compound's application in clinical settings and improving patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 672309-93-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,2,3,0 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 672309-93:
(8*6)+(7*7)+(6*2)+(5*3)+(4*0)+(3*9)+(2*9)+(1*3)=172
172 % 10 = 2
So 672309-93-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO4/c15-11-5-7-14(8-6-11)12(16)9-1-3-10(4-2-9)13(17)18/h1-4H,5-8H2,(H,17,18)
672309-93-2Relevant academic research and scientific papers
SUBSTITUTED BIPIPERIDINYL DERIVATIVES
-
, (2016/11/17)
The invention relates to novel substituted bipiperidinyl derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.
